Psychiatry

 
Depression, Anxiety in Youth with Chronic Pain: Daily Dose
October 15, 2024

Your daily dose of the clinical news you may have missed.

Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
October 14, 2024

Your daily dose of the clinical news you may have missed.

FDA Black-Box Warnings on Antidepressants Linked to Reduced Treatment, Increased Risk of Suicide Among Youth
October 08, 2024

The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.

FDA Approves First-in-Class Schizophrenia Drug: Daily Dose
October 07, 2024

Your daily dose of the clinical news you may have missed.

Youth with Chronic Pain Face Greater Symptoms of Depression, Anxiety than Pain-Free Peers
October 02, 2024

Findings from a systematic review and meta-analysis showed 1 in 3 youth with chronic pain were diagnosed with anxiety and 1 in 8 were diagnosed with depression.

Suicide Attempts Reduced by 25% with Integrated Primary Care Intervention
October 01, 2024

A 14% increase in the rates of primary care safety planning within 2 weeks of a negative screening was associated 25% drop in the rate of attempted suicides.

FDA Approves First-in-Class Schizophrenia Drug, Described as "Quantum Leap Forward"
September 27, 2024

Cobenfy, previously KarXT, is the first new agent with a novel mechanism of action for schizophrenia in more than 50 years, according to BMS.

Mental Health Among Adolescents With Obesity: Daily Dose
September 16, 2024

Your daily dose of the clinical news you may have missed.

Lebrikizumab Therapy Improved QoL, Mental Health Outcomes in Patients with Atopic Dermatitis
September 10, 2024

In a study of persons with moderate-to-severe atopic dermatitis, lebrikizumab monotherapy for 16 weeks resulted in improved quality of life and mental health.

PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose
August 29, 2024

Your daily dose of the clinical news you may have missed.